Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Vividion Therapeutics
Vividion is a biotechnology company that develops drug discovery platform.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
BlackThorn Therapeutics
BlackThorn Therapeutics develops precision medicine for CNS disorders by targeting dysfunctional brain circuits.
Sector
Subsector
Location
total rounds
total raised
AbCellera Biologics
AbCellera is a Vancouver-based company focused on antibody discovery and immune profiling.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
ZetaGen Therapeutics
Zetagen is a biopharmaceutical company focused on developing innovative treatments for metastatic bone cancers and osteologic interventions.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 17.04.2024. Their latest investor Epidarex Capital. Their latest round Venture - Series Unknown
Sound Bioventures
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Sector
Subsector
Keywords
Location
count Of Investments
Taiho Ventures
Taiho Ventures is a venture capital firm that invests in early-stage pharmaceutical companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Epidarex Capital
Epidarex Capital is a venture capital firm that invests in early-stage life science and health technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
Epidarex Capital
Epidarex Capital is a venture capital firm that invests in early-stage life science and health technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
M Ventures
Merck Ventures is investing in innovative technologies and products that can impact Merck's core business areas.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Taiho Ventures
Taiho Ventures is a venture capital firm that invests in early-stage pharmaceutical companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders4
Margaret Duffy
Margaret is committed to the translation of innovative biological approaches into viable patient care. With over ten years’ international research experience, she specialises in virology and leads the scientific teams in the discovery of powerful new oncolytic viruses for clinical development. Previously a Fellow with the Kay Kendall Leukaemia Fund at the University of Oxford, Margaret also spent several years as a Postdoctoral Researcher with the University of Glasgow and with Batavia Biosciences in Leiden as part of the Marie Curie Industry-Academia Partnerships programme. Margaret has a PhD in Adenoviral Gene Therapy from the University of Glasgow.
current job
organization founded
Margaret Duffy
Charlotte Casebourne
Charlotte believes in equitable access to effective therapies. In addition to her role with Theolytics, she is a Board Member of the UK BioIndustry Association. She has also been recently named one of In Vivo‘s 30 Rising Leaders in Life Sciences.
current job
organization founded
Charlotte Casebourne
Kerry Fisher
Kerry Fisher is the Co-Founder at Theolytics. kerry is the University of Birmingham.
current job
organization founded
Kerry Fisher
Leonard Seymour
Len is the Founder & Chief Scientific Officer of Oxford Genetics. He is a Professor of Gene Therapies at the University of Oxford and has over 25 years of experience at the interface of genetic engineering and medicine. His main interests are in designing viruses and other micro-organisms for targeted cancer treatment. He has published over 200 primary scientific papers, was a founder of the British Society for Gene Therapy, and is currently the Secretary of the European Society of Gene and Cell Therapy. As co-founder of Oxford Genetics, Len provides key scientific insight to help establish the company as world leader in DNA design and modular cloning, providing increased versatility and removing the inefficiencies that have plagued the technology in the past.
current job
organization founded
Leonard Seymour
Employee Profiles3
Activity
Recent News3
The graph reveals the ratio (%) of positive news articles in a chosen time range